Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years

Chemotherapy
Marc PrachtEveline Boucher

Abstract

Systemic chemotherapy is the treatment of choice for inoperable (advanced or metastatic) cholangiocarcinoma. According to phase II and III trials, regimens combining 5-fluorouracil (5FU) or gemcitabine with a platinum salt have provided an overall response rate of 12-50% with a median overall survival of 5-16 months. This was a retrospective analysis of 78 consecutive cases of inoperable cholangiocarcinoma treated by palliative chemotherapy from July 2005 to November 2009 in one center. We firstly aimed to evaluate the impact of palliative chemotherapy in terms of survival and secondly to analyze possible related prognostic factors. This cohort included 25 female and 53 male patients, with a mean age of 60.8 ± 11.4 years. Intrahepatic and extrahepatic cholangiocarcinoma were observed in 57 and 21 patients, respectively. First-line chemotherapy regimens were as follows: gemcitabine (n = 7), gemcitabine plus oxaliplatin (with or without cetuximab; n = 62) and 5FU plus cisplatin (n = 9). None of the patients achieved a complete response. The partial response rate was 35.9% (27/78), and the stable disease rate was 26.9% (21/78), giving a disease control rate of 62.8%. At the time of this analysis, with a median follow-up of 18 mont...Continue Reading

References

Aug 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GlimeliusC Svensson
Oct 28, 1999·The New England Journal of Medicine·P C de GroenD M Nagorney
Apr 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gregory J Gores
May 28, 2004·Expert Opinion on Pharmacotherapy·Imtiaz A Malik
Nov 4, 2004·Gastroentérologie Clinique Et Biologique·Anne-Marie BouvierJean Faivre
Feb 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M DucreuxUNKNOWN EORTC Gastro Intestinal Tract Cancer Group
Mar 11, 2005·Journal of Vascular and Interventional Radiology : JVIR·Ingrid BurgerJean-Francois H Geschwind
Mar 15, 2005·Gastroenterology·Yasser H ShaibKatherine A McGlynn
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LouvetUNKNOWN GISCAD
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip A PhilipCharles Erlichman
Feb 28, 2007·British Journal of Cancer·F Eckel, R M Schmid
May 15, 2008·Cardiovascular and Interventional Radiology·Camillo AlibertiGiammaria Fiorentini
May 22, 2008·World Journal of Gastroenterology : WJG·Candace WiseShannon-S Glaser
May 29, 2008·World Journal of Gastroenterology : WJG·Mirna H FarhatKassem A Barada
Jun 7, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Boris Blechacz, Gregory J Gores
Sep 6, 2008·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·C VerslypeE Van Cutsem
Nov 26, 2008·World Journal of Gastroenterology : WJG·Yucel Ustundag, Yusuf Bayraktar
Jan 27, 2009·Cancer Chemotherapy and Pharmacology·Ramesh K RamanathanDavid R Gandara
Feb 25, 2009·British Journal of Cancer·T AndréW Scheithauer
May 2, 2009·Journal of the National Comprehensive Cancer Network : JNCCN·Kwang-Yu ChangYun Yen
Sep 15, 2009·World Journal of Gastroenterology : WJG·Murad AljiffryMichele Molinari
Nov 26, 2009·British Journal of Cancer·C BengalaP Conte
Jan 26, 2010·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Manuela GattoDomenico Alvaro
Apr 9, 2010·The New England Journal of Medicine·Juan ValleUNKNOWN ABC-02 Trial Investigators
Jun 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sam J LubnerKyle D Holen

❮ Previous
Next ❯

Citations

Jan 23, 2016·Journal of Surgical Oncology·Kerri A SimoJohn B Martinie
Aug 8, 2017·The British Journal of Surgery·T MaetaUNKNOWN Nagoya Surgical Oncology Group
Feb 27, 2015·World Journal of Gastroenterology : WJG·Jean-Florian Guion-DusserreFrancois Ghiringhelli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.